PL2111868T3 - Zastosowanie ludzkiej albuminy do wytwarzania leku do leczenia pacjentów cierpiących na zaburzenia funkcji poznawczych - Google Patents
Zastosowanie ludzkiej albuminy do wytwarzania leku do leczenia pacjentów cierpiących na zaburzenia funkcji poznawczychInfo
- Publication number
- PL2111868T3 PL2111868T3 PL08380301T PL08380301T PL2111868T3 PL 2111868 T3 PL2111868 T3 PL 2111868T3 PL 08380301 T PL08380301 T PL 08380301T PL 08380301 T PL08380301 T PL 08380301T PL 2111868 T3 PL2111868 T3 PL 2111868T3
- Authority
- PL
- Poland
- Prior art keywords
- drug
- preparation
- treatment
- patients suffering
- human albumin
- Prior art date
Links
- 102000008100 Human Serum Albumin Human genes 0.000 title 1
- 108091006905 Human Serum Albumin Proteins 0.000 title 1
- 208000010877 cognitive disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200702831A ES2332846B1 (es) | 2007-10-26 | 2007-10-26 | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
| EP08380301.5A EP2111868B1 (en) | 2007-10-26 | 2008-10-22 | Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2111868T3 true PL2111868T3 (pl) | 2014-01-31 |
Family
ID=40583637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08380301T PL2111868T3 (pl) | 2007-10-26 | 2008-10-22 | Zastosowanie ludzkiej albuminy do wytwarzania leku do leczenia pacjentów cierpiących na zaburzenia funkcji poznawczych |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7851446B2 (pl) |
| EP (1) | EP2111868B1 (pl) |
| JP (1) | JP5437619B2 (pl) |
| CN (1) | CN101417123B (pl) |
| AR (1) | AR068901A1 (pl) |
| AU (1) | AU2008233025B8 (pl) |
| BR (1) | BRPI0804623B8 (pl) |
| CA (1) | CA2641830C (pl) |
| CL (1) | CL2008003133A1 (pl) |
| ES (2) | ES2332846B1 (pl) |
| MX (1) | MX2008013635A (pl) |
| NZ (1) | NZ572131A (pl) |
| PL (1) | PL2111868T3 (pl) |
| PT (1) | PT2111868E (pl) |
| RU (1) | RU2414925C2 (pl) |
| UY (1) | UY31418A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10112000B2 (en) | 2010-07-08 | 2018-10-30 | Asahi Kasei Medical Co., Ltd. | Method for reducing amyloid beta concentration in blood |
| US10525107B2 (en) | 2016-08-18 | 2020-01-07 | Alkahest, Inc. | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
| MY202968A (en) * | 2016-08-18 | 2024-05-31 | Alkahest Inc | Blood plasma fractions as a treatment for aging-associated cognitive disorders |
| US11040068B2 (en) | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| MA48480A (fr) * | 2017-04-26 | 2020-03-04 | Alkahest Inc | Schéma posologique pour le traitement de déficiences cognitives et motrices avec du plasma sanguin et des produits de plasma sanguin |
| BR112021000653A2 (pt) * | 2018-07-20 | 2021-04-13 | Alkahest, Inc. | Regime de dosagem para tratamento de comprometimentos cognitivo e motor com plasma sanguíneo e produtos de plasma sanguíneo |
| EP3643319A1 (en) * | 2018-10-25 | 2020-04-29 | Grifols Worldwide Operations Limited | Use of low volume plasma exchange for the treatment of alzheimer's disease in early and middle stages |
| CN119345230A (zh) | 2018-10-26 | 2025-01-24 | 万能溶剂有限公司 | 血浆和血浆组分用于改善疼痛的用途 |
| CA3200309A1 (en) * | 2020-10-30 | 2022-05-05 | Shenzhen Protgen Ltd. | Use of human serum albumin in treatment of diseases |
| CN117202949A (zh) * | 2021-04-30 | 2023-12-08 | 基立福环球运营有限公司 | 治疗性血浆置换和低容量血浆置换用于治疗认知损害的用途 |
| WO2025230830A1 (en) | 2024-04-29 | 2025-11-06 | Alkahest, Inc. | Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3612137A1 (de) | 1986-04-10 | 1987-10-15 | Biotest Pharma Gmbh | Steriles plasmaaustauschmittel |
| US5112298A (en) | 1990-06-25 | 1992-05-12 | Baxter International Inc. | Apheresis method and device |
| US5178603A (en) | 1990-07-24 | 1993-01-12 | Baxter International, Inc. | Blood extraction and reinfusion flow control system and method |
| US6627151B1 (en) * | 1997-06-13 | 2003-09-30 | Helmut Borberg | Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion |
| CA2408566A1 (en) | 2000-05-23 | 2001-11-29 | Berislav V. Zlokovic | Role of ldl receptor protein-1 (lrp-1) in alzheimer's disease |
| EP1370240A4 (en) * | 2001-03-02 | 2004-09-22 | Neuron Therapeutics Inc | NEUROPROTECTOR FORMULATIONS AND METHOD |
| US20050227941A1 (en) | 2001-12-17 | 2005-10-13 | Karen Duff | Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases |
| JP4690043B2 (ja) | 2002-10-04 | 2011-06-01 | プラナ バイオテクノロジー リミティッド | 神経に対し活性な化合物 |
| US20070010435A1 (en) | 2002-12-19 | 2007-01-11 | New York University | Method for treating amyloid disease |
| JP2006517938A (ja) | 2003-02-13 | 2006-08-03 | オクタファルマ アクチェン ゲゼルシャフト | アルブミン溶液およびその調製のための製法 |
| CA2532207A1 (en) | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| AT413336B (de) * | 2003-09-12 | 2006-02-15 | Mattner Frank Dr | Apherese-vorrichtung |
| US20050182044A1 (en) | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
| AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| RU2261702C1 (ru) * | 2004-09-23 | 2005-10-10 | Смирнов Алексей Владимирович | Способ лечения гипергомоцистеинемии у больных с хронической почечной недостаточностью, получающих лечение гемодиализом или гемофильтрацией |
| RU2281090C2 (ru) * | 2004-09-23 | 2006-08-10 | Алексей Владимирович Смирнов | Способ лечения больных хронической почечной недостаточностью |
| US7436304B1 (en) | 2005-07-19 | 2008-10-14 | Visible Assets, Inc | Evidence tracking |
-
2007
- 2007-10-26 ES ES200702831A patent/ES2332846B1/es not_active Expired - Fee Related
-
2008
- 2008-10-17 RU RU2008141076/15A patent/RU2414925C2/ru active
- 2008-10-17 AR ARP080104523A patent/AR068901A1/es unknown
- 2008-10-17 NZ NZ572131A patent/NZ572131A/en unknown
- 2008-10-22 ES ES08380301T patent/ES2428698T3/es active Active
- 2008-10-22 PL PL08380301T patent/PL2111868T3/pl unknown
- 2008-10-22 EP EP08380301.5A patent/EP2111868B1/en active Active
- 2008-10-22 PT PT83803015T patent/PT2111868E/pt unknown
- 2008-10-23 CL CL2008003133A patent/CL2008003133A1/es unknown
- 2008-10-23 UY UY31418A patent/UY31418A1/es not_active Application Discontinuation
- 2008-10-23 CN CN2008101705786A patent/CN101417123B/zh active Active
- 2008-10-23 MX MX2008013635A patent/MX2008013635A/es active IP Right Grant
- 2008-10-23 BR BRPI0804623A patent/BRPI0804623B8/pt active IP Right Grant
- 2008-10-24 AU AU2008233025A patent/AU2008233025B8/en active Active
- 2008-10-24 CA CA2641830A patent/CA2641830C/en active Active
- 2008-10-24 JP JP2008274076A patent/JP5437619B2/ja active Active
- 2008-10-24 US US12/257,814 patent/US7851446B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0804623B1 (pt) | 2020-02-11 |
| UY31418A1 (es) | 2009-05-29 |
| CA2641830C (en) | 2013-07-16 |
| RU2414925C2 (ru) | 2011-03-27 |
| BRPI0804623B8 (pt) | 2021-05-25 |
| CN101417123B (zh) | 2012-06-27 |
| BRPI0804623A2 (pt) | 2009-06-30 |
| JP5437619B2 (ja) | 2014-03-12 |
| ES2428698T3 (es) | 2013-11-08 |
| CA2641830A1 (en) | 2009-04-26 |
| EP2111868A1 (en) | 2009-10-28 |
| EP2111868B1 (en) | 2013-08-21 |
| PT2111868E (pt) | 2013-10-17 |
| CL2008003133A1 (es) | 2009-08-07 |
| RU2008141076A (ru) | 2010-04-27 |
| ES2332846B1 (es) | 2010-07-08 |
| MX2008013635A (es) | 2009-05-11 |
| JP2009108059A (ja) | 2009-05-21 |
| AU2008233025B8 (en) | 2013-07-25 |
| NZ572131A (en) | 2010-06-25 |
| ES2332846A1 (es) | 2010-02-12 |
| AU2008233025A1 (en) | 2009-05-14 |
| HK1126689A1 (en) | 2009-09-11 |
| US7851446B2 (en) | 2010-12-14 |
| AU2008233025B2 (en) | 2013-06-27 |
| AR068901A1 (es) | 2009-12-16 |
| CN101417123A (zh) | 2009-04-29 |
| US20090111740A1 (en) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2111868T3 (pl) | Zastosowanie ludzkiej albuminy do wytwarzania leku do leczenia pacjentów cierpiących na zaburzenia funkcji poznawczych | |
| EP2166837A4 (en) | DRUG COMBINATION USEFUL FOR THE TREATMENT OF SKIN DISORDERS | |
| IL217901B (en) | Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases | |
| IL202515A (en) | Thyroid-like compounds and their use in the preparation of drugs for the treatment of @ metabolic diseases | |
| IL188204A0 (en) | Combination therapy for the treatment of immunoinflammatory disorders | |
| IL213407A (en) | Use of combinations of drug factors to prepare combination therapy drugs | |
| IL184425A0 (en) | Cxcr4 antagonists for the treatment of medical disorders | |
| AP2037A (en) | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases | |
| IL182105A0 (en) | Use of memantine for the preparation of a medicament for the treatment of childhood behavioral disorders | |
| IL177015A0 (en) | Improved modalities for the treatment of degenerative diseases of the retina | |
| IL261742B (en) | Human antibodies and their diagnostic and therapeutic uses for the treatment of neurological diseases | |
| ZA200801667B (en) | Novel pharmaceutical combinations for the treatment of respiratory disorders | |
| TWI372056B (en) | Novel medicament combinations for the treatment of respiratory diseases | |
| EP2306824A4 (en) | IONTOPHORETIC DELIVERY OF CURCUMINE AND CURCUMINANALOGUE FOR THE TREATMENT OF MORBUS ALZHEIMER | |
| PL1670482T3 (pl) | Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego | |
| UA81573C2 (en) | Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients | |
| IL206435A0 (en) | Therapeutic regimens for the treatment of immunoinflammatory disorders | |
| EP1838316A4 (en) | MACROCYCLIC ANALOGUES USEFUL FOR THE TREATMENT OF IMMUNOREGULATION DISORDERS AND RESPIRATORY DISEASES | |
| IL207977A0 (en) | Therapy for disorders of the proximal digestive tract | |
| EP2059238A4 (en) | THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS | |
| PT2344166E (pt) | Composição farmacêutica para o tratamento da irritação gastrointestinal | |
| ZA200505996B (en) | Combination therapy for the treatment of immunoinflammatory disorders | |
| HRP20040104A2 (en) | Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders | |
| PL1714647T3 (pl) | Zastosowanie agomelatyny do wytwarzania leku do leczenia zaburzeń dwubiegunowych | |
| IL178120A0 (en) | Therapeutic combination for treatment of alzheimers disease |